EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Potential of Beaucarnea recurvata Leaf Extract Against Ulcerative Colitis: Integrating Phytochemical Profiling, Network Pharmacology, and Experimental Validation

Nora Tawfeek, Raha Orfali, Shagufta Perveen iD, Safina Ghafar, Eman Fikry iD, Mahmoud H Elbatreek iD, Samar S Elbaramawi iD, Maher M El-Domiaty, Azza M El-Shafae iD

International Journal of Molecular Sciences · 15.12.2025 · 26 (24) · 12053

DOI: 10.3390/ijms262412053 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 15.12.2025. Verfasst von Nora Tawfeek und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Plant Extracts, Plant Leaves, Phytochemicals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 133 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: King Saud University, Ongoing Research Funding program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ulcerative colitis represents a chronic inflammatory bowel disease with limited therapeutic options due to inadequate efficacy and adverse effects of current treatments. This study investigated the therapeutic potential of Beaucarnea recurvata leaf extract (BRLE) against ulcerative colitis using integrated computational and experimental approaches to address the need for safer, multi-targeted interventions. Phytochemical profiling was performed using UPLC-ESI-MS/MS analysis. Network pharmacology and molecular docking predicted therapeutic targets and mechanisms. In vivo validation employed an acetic acid-induced ulcerative colitis rat model with BRLE treatment at 100, 200, and 400 mg/kg doses, evaluating clinical parameters, histopathology, oxidative stress markers, inflammatory cytokines, and protein expression. UPLC-ESI-MS/MS revealed diverse bioactive compounds including steroidal saponins, triterpenes, and flavonoids. Network pharmacology identified 24 hub targets, and molecular docking revealed strong binding affinities (−6.5 to −9.1 kcal/mol) between BRLE compounds and inflammatory proteins including EGFR, SRC, STAT3, and AKT1. BRLE at 200 mg/kg significantly improved disease activity, restored glutathione levels, reduced malondialdehyde, normalized IL-10 and TNF-α levels, downregulated EGFR, SRC, STAT3, and AKT1 expression, and enhanced mucosal healing with reduced inflammatory infiltration. BRLE demonstrates significant anti-inflammatory, antioxidant, and tissue-protection effects through multi-target mechanisms, representing a promising therapeutic intervention for ulcerative colitis treatment. Further studies in chronic models, pharmacokinetic assessments, and clinical trials are needed to support its translation into therapeutic use.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Colitis, UlcerativePlant ExtractsPlant LeavesPhytochemicalsAnimalsNetwork PharmacologyMolecular Docking SimulationRatsMaleOxidative StressDisease Models, AnimalRats, Sprague-DawleyCytokines

Stichwörter der Autor:innen

Beaucarnea recurvataanti-inflammatoryinflammatory bowel diseasenetwork pharmacologysteroidal saponinsulcerative colitis

Substanzen

Plant ExtractsPhytochemicalsCytokines

Autor:innen und Institutionen

  • Department of Pharmacognosy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
  • Department of Pharmacognosy, College of Pharmacy, King Saud University, P.O. Box 2457, Riyadh 11451, Saudi Arabia.
  • Department of Bacteriology, University of Wisconsin-Madison, Madison, WI 53706, USA.
  • Department of Pharmacology and Toxicology, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.
  • Department of Medicinal Chemistry, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt.

ORCID-Profile: Shagufta Perveen, Eman Fikry, Mahmoud H Elbatreek, Samar S Elbaramawi, Azza M El-Shafae

Förderung

  • King Saud University
  • Ongoing Research Funding program

Zitieren

APA

Tawfeek, N., Orfali, R., Perveen, S., Ghafar, S., Fikry, E., Elbatreek, M. H., Elbaramawi, S. S., El-Domiaty, M. M., & El-Shafae, A. M. (2025). Therapeutic Potential of Beaucarnea recurvata Leaf Extract Against Ulcerative Colitis: Integrating Phytochemical Profiling, Network Pharmacology, and Experimental Validation. International Journal of Molecular Sciences, 26(24), 12053. https://doi.org/10.3390/ijms262412053

Vancouver

Tawfeek N, Orfali R, Perveen S, Ghafar S, Fikry E, Elbatreek MH, et al. Therapeutic Potential of Beaucarnea recurvata Leaf Extract Against Ulcerative Colitis: Integrating Phytochemical Profiling, Network Pharmacology, and Experimental Validation. International Journal of Molecular Sciences. 2025;26(24):12053. doi:10.3390/ijms262412053

BibTeX
@article{Tawfeek2025,
  author = {Tawfeek, Nora and Orfali, Raha and Perveen, Shagufta and Ghafar, Safina and Fikry, Eman and Elbatreek, Mahmoud H and Elbaramawi, Samar S and El-Domiaty, Maher M and El-Shafae, Azza M},
  title = {Therapeutic Potential of Beaucarnea recurvata Leaf Extract Against Ulcerative Colitis: Integrating Phytochemical Profiling, Network Pharmacology, and Experimental Validation},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {24},
  pages = {12053},
  doi = {10.3390/ijms262412053}
}
Kostenlos starten →